GI-NEU

IMPACT OF COLOSTRUM-BASED NEUTRACEUTICALS ON FUNCTIONAL GASTROINTESTINAL DISORDERS

 Coordinatore ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS 

 Organization address address: CHARILAOU THERMI ROAD 6 KM
city: THERMI THESSALONIKI
postcode: 57001

contact info
Titolo: Mrs.
Nome: Georgia
Cognome: Pahlitzanakis
Email: send email
Telefono: 302421000000
Fax: 302421000000

 Nazionalità Coordinatore Greece [EL]
 Totale costo 646˙672 €
 EC contributo 646˙672 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2012-IAPP
 Funding Scheme MC-IAPP
 Anno di inizio 2013
 Periodo (anno-mese-giorno) 2013-10-01   -   2017-09-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS

 Organization address address: CHARILAOU THERMI ROAD 6 KM
city: THERMI THESSALONIKI
postcode: 57001

contact info
Titolo: Mrs.
Nome: Georgia
Cognome: Pahlitzanakis
Email: send email
Telefono: 302421000000
Fax: 302421000000

EL (THERMI THESSALONIKI) coordinator 214˙344.02
2    IMEDICA SA

 Organization address address: STRADA SOS BUCURESTI PLOIESTI 141D
city: BUCARESTI
postcode: 13686

contact info
Titolo: Dr.
Nome: Octaviu
Cognome: Moldovan
Email: send email
Telefono: 40012315110

RO (BUCARESTI) participant 164˙083.44
3    KALITE SISTEM LABORATUVARLARI AS

 Organization address address: Degirmen sok Ar Plaza B Blok 16
city: Istanbul
postcode: 34742

contact info
Titolo: Mrs.
Nome: Tugce
Cognome: Sagdur Akdik
Email: send email
Telefono: 902164000000
Fax: 902164000000

TR (Istanbul) participant 140˙143.56
4    UNIVERSITA DEGLI STUDI DELLA TUSCIA

 Organization address address: VIA S MARIA IN GRADI 4
city: VITERBO
postcode: 1100

contact info
Titolo: Dr.
Nome: Agnese
Cognome: Apuzza
Email: send email
Telefono: +39 0761 357438
Fax: +39 0761 357434

IT (VITERBO) participant 128˙101.36

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

partnership    sectors    gastrointestinal    colostrum    neutraceuticals    joint    disorders    functional    commercial   

 Obiettivo del progetto (Objective)

'The aim of this proposal is to create a multiannual joint programme of collaboration between research-intensive non-commercial (academic) and commercial (industry) organisations to increase knowledge on the effects of colostrum-based neutraceuticals on functional gastrointestinal disorders (FGID). Functional gastrointestinal disorders such as irritable bowel syndrome represent well-known issues, yet the vast majority of attempts to address them to date have been led by either the public or the private sector alone. The current proposal is designed to exploit the complimentary expertise of non-commercial and commercial organisations through knowledge sharing and transfer between sectors. This will be achieved by establishing a Network of Excellence (NoE) that will incorporate staff secondments and the recruitment of researchers from outside the partnership for the purpose of networking, training activities, workshops, and joint research. Thus, this proposal will foster mutual understanding of the different cultural settings and skill requirements of the non-commercial and commercial sectors, encouraging entrepreneurship and long-term intersectoral collaboration regarding the effects of colostrum-based neutraceuticals on functional gastrointestinal disorders. Eventually, this partnership may help translate creative ideas into innovative products and processes that can efficiently address existing challenges on gastrointestinal issues.'

Altri progetti dello stesso programma (FP7-PEOPLE)

TRANSICAP (2013)

Labour trajectories in UK and Spain. Analysis of capabilities in transitions using a mixed-method approach

Read More  

IMAGINDNA (2013)

Advanced DNA imaging: improving spatial resolution and contrast through photoswitching

Read More  

PI3KACT (2011)

Dynamic regulation of Ras signaling – a novel way to attenuate PI3K activity in cancer and inflammation

Read More